Your browser doesn't support javascript.
loading
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; Chovanec, Michal; Winquist, Eric; Grimison, Peter; Feldman, Darren R; Terbuch, Angelika; Hentrich, Marcus; Bokemeyer, Carsten; Negaard, Helene; Fankhauser, Christian; Shamash, Jonathan; Vaughn, David J; Sternberg, Cora N; Heidenreich, Axel; Beyer, Jörg.
Affiliation
  • Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Sauvé N; Universita della Svizzera Italiana, Lugano, Switzerland.
  • Collette L; University of Manchester, Manchester, United Kingdom.
  • Daugaard G; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • de Wit R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Albany C; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Tryakin A; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Fizazi K; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.
  • Stahl O; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.
  • Gietema JA; Research Institute of Oncology at Bashkir State Medical University, Ufa, Russian Federation.
  • De Giorgi U; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Cafferty FH; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Hansen AR; University Medical Center Groningen, Groningen, the Netherlands.
  • Tandstad T; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG).
  • Huddart RA; Medical Research Council Clinical Trials Unit, University College London (UCL), London, United Kingdom.
  • Necchi A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Sweeney CJ; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
  • Garcia-Del-Muro X; Institute of Cancer Research, Sutton, United Kingdom.
  • Heng DYC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Current Affiliation: Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.
  • Lorch A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Chovanec M; Catalan Institute of Oncology, IDIBELL Institute of Research, University of Barcelona, Barcelona, Spain.
  • Winquist E; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
  • Grimison P; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Feldman DR; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany.
  • Terbuch A; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.
  • Hentrich M; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Bokemeyer C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia.
  • Negaard H; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Fankhauser C; Weill Medical College of Cornell University, New York, NY.
  • Shamash J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Vaughn DJ; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany.
  • Sternberg CN; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Heidenreich A; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Beyer J; University of Zurich, Zurich, Switzerland.
J Clin Oncol ; 39(14): 1563-1574, 2021 05 10.
Article in En | MEDLINE | ID: mdl-33822655
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: